In this large retrospective cohort from a single VA center, researchers compared the risk of bleeding after polypectomy in patients on or not on plavix. They found the risk of immediate bleeding was the same, but the risk of delayed bleeding (1-4 days) was higher in the plavix group (3.5% vs 1%), which was much higher in those on concomitant ASA or NSAID (with an odds ratio of bleeding of 3.7 in those on concomitant ASA/NSAIDs versus plavix alone). Given the risk of bleeding is higher with plavix, but the absolute risk of bleeding is low, the decision to discontinue plavix before polypectomy should be made on a case by case basis, but concomitant plavix with ASA/NSAID before polypectomy should be avoided (abstract).
Share This Post
Categories
Related Posts
Do you have a stack of journals piling up on your desk, beside your bed or in your email inbox? In 1950, medical knowledge was estimated to double every 50 years, but now the doubling time is every few months. At this rate, it is impossible to keep up with the literature, but a group […]
This large systematic review found rectal NSAIDs significantly reduced the risk of post-ERCP pancreatitis compared to pancreatic duct stents (abstract).
This large population-based cohort found the most common causes of drug induced liver injury to be augmentin and diclofenac, followed by herbal and nutritional supplements (abstract).
Leave A Comment